ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Regulatory Guidance For PRO Strategy In Oncology Trials

  Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits

  Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.

• Revitalizing Recruitment In A Lupus Rescue Study

  Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.

• RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk

  This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

• Why Site Training Still Slows Site Activation

  Effective site training relies on clear, accessible, up-to-date materials that reflect real workflows — keeping sites aligned, compliant, and confident throughout the study lifecycle.

• Beyond The Pandemic: Why eCOAs Are Here To Stay

  The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.

• PEAK Matrix® For Decentralized Clinical Trial Platforms Provider 2023

  Explore how technological advancements, innovative business models, increased wearables support, FDA’s push to the industry to adopt DCTs, and a holistic approach to clinical trials have proliferated the DCT landscape.

• Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies

  See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.

• Top 10 HEOR Trends Report

  Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.